Changeflow GovPing Healthcare & Life Sciences Robotic Bronchoscopy Synchronous Biopsy and Rad...
Routine Notice Added Final

Robotic Bronchoscopy Synchronous Biopsy and Radiofrequency Ablation Study

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

A prospective, single-arm, open-label clinical study (NCT07545057) registered April 22, 2026, evaluating the feasibility of synchronous biopsy and radiofrequency ablation for pulmonary nodules suspected to be malignant under robotic-assisted bronchoscopy. The study is sponsored by an institutional investigator and registered on ClinicalTrials.gov as part of standard clinical research transparency requirements.

“This is a prospective, single-arm, open-label clinical study.”

NIH , verbatim from source
Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov Studies for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 637 changes logged to date.

What changed

ClinicalTrials.gov registered a new prospective, single-arm, open-label feasibility study (NCT07545057) on April 22, 2026. The study will evaluate robotic-assisted bronchoscopy-guided synchronous biopsy and radiofrequency ablation as a combined diagnostic and therapeutic approach for pulmonary nodules suspected to be malignant. This is an institutional clinical research registration entry with no compliance obligations or regulatory mandates. Healthcare institutions conducting interventional pulmonary research and medical device manufacturers involved in robotic bronchoscopy platforms may monitor this study for outcomes data that could inform future clinical practice and device development pathways.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Robotic-Assisted Bronchoscopy-Guided Synchronous Biopsy and Radiofrequency Ablation for Pulmonary Nodules

N/A NCT07545057 Kind: NA Apr 22, 2026

Abstract

This is a prospective, single-arm, open-label clinical study. The primary study objective is to evaluate the feasibility of synchronous biopsy and radiofrequency ablation for pulmonary nodules under robotic-assisted bronchoscopy.

Conditions: Pulmonary Nodules Suspected to be Malignant

Interventions: Robotic-assisted bronchoscopy-guided synchronous biopsy and radiofrequency ablation for pulmonary nodules

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 22nd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Medical procedure research
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Medical Devices Pharmaceuticals

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!